X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
https://www.biospace.com/article/releases/vertex-announces-health-canada-market-authorization-for-orkambi-and-174-lumacaftor-ivacaftor-in-children-with-cystic-fibrosis-ages-1-to-and-lt-2-years/
https://www.nasdaq.com/articles/vertex-vrtx-cf-drug-gets-fda-expanded-label-for-toddlers
https://icer-review.org/announcements/icer-issues-final-report-and-policy-recommendations-on-treatments-for-cystic-fibrosis/
https://investors.vrtx.com/news-releases/news-release-details/vertex-announces-innovative-reimbursement-agreement-switzerland
https://www.reuters.com/article/us-britain-cystic-fibrosis-drug/vertex-deal-with-wales-expands-cystic-fibrosis-treatment-coverage-to-all-of-uk-idUSKBN1XN1IK
http://www.pharmafile.com/news/533429/vertexs-cystic-fibrosis-portfolio-be-made-available-across-northern-ireland-and-wales
http://www.pmlive.com/pharma_news/labour_party_takes_aim_at_pharma,_calls_attention_to_orkambi_row_1302545
https://www.fiercepharma.com/manufacturing/u-k-s-labour-party-wants-government-to-build-its-own-manufacturing-to-lower-drug
http://www.pmlive.com/pharma_news/vertex_faces_rejection_of_its_cf_medicines_in_scotland_1297326
https://www.fiercepharma.com/pharma/vertex-touts-success-symdeko-despite-ceo-turnover-orkambi-stumble
http://www.pmlive.com/pharma_news/orkambi_row_government_says_now_considering_crown_licensing_1290525
https://www.fiercebiotech.com/biotech/orkambi-debate-u-k-revives-myth-a-people-s-funded-drug
http://www.pmlive.com/pharma_news/vertex_makes_choice_for_all-important_cf_triple_therapy_1289543
http://www.pmlive.com/pharma_news/still_no_breakthrough_on_orkambi_talks,_mps_want_answers_1289016
https://www.fiercepharma.com/pharma/cf-patients-and-families-keep-up-pressure-vertex-u-k-officials
https://www.fiercepharma.com/pharma/vertex-destroys-nearly-8-000-orkambi-packs-amid-u-k-pricing-standoff
https://www.fiercepharma.com/pharma/vertex-ceo-english-officials-air-orkambi-arguments-at-parliamentary-hearing
http://www.pmlive.com/pharma_news/unruffled_by_outlier_claims,_vertex_ceo_upbeat_on_orkambi_breakthrough_1280799
http://www.pmlive.com/pharma_news/how_to_fix_a_problem_like_orkambi_solutions_suggested_ahead_of_showdown_1280492
https://www.fiercepharma.com/pharma/vertex-ceo-cco-set-to-appear-at-u-k-hearing-cf-drug-standoff
https://www.theguardian.com/society/2019/feb/10/vertex-revenue-hike-orkambi-drug-nhs
https://endpts.com/mps-threaten-to-hijack-vertexs-ip-for-its-cystic-fibrosis-drugs-in-a-long-running-standoff-over-price/
http://www.pharmatimes.com/news/vertex_to_submit_orkambi,_symkevi_to_smc_1273272
https://www.statnews.com/pharmalot/2018/12/13/catalyst-drug-prices-fentanyl/
http://www.pharmatimes.com/news/mps_order_release_of_documents_on_negotiations_for_vertex_cf_drugs_1259705
https://www.fiercepharma.com/pharma/abbvie-muscles-into-cystic-fibrosis-but-vertex-ceo-says-its-competitive-edge-has-improved
https://investors.vrtx.com/news-releases/news-release-details/vertex-announces-access-contract-denmark-current-and-future
https://www.biopharmadive.com/news/pharmas-slow-embrace-of-continuous-manufacturing/532811/
https://www.biocentury.com/bc-extra/company-news/2018-09-04/vertex-finalizes-orkambi-deal-australia
https://pharmaphorum.com/news/vertexs-orkambi-cf-drug-okayed-for-funding-in-australia/
https://www.fiercepharma.com/pharma/vertex-says-it-s-glad-nhs-england-made-another-offer-for-cf-drugs-but-it-ll-have-to-do
https://pharmaphorum.com/news/nhs-does-not-value-cf-patients-says-vertex-ceo-in-letter-to-pm/
https://endpts.com/vertex-ceo-to-uk-prime-minister-youre-devaluing-lives-passing-up-a-great-offer-and-threatening-the-countrys-biotech-industry/
https://www.fiercepharma.com/pharma/patients-wait-for-years-as-vertex-u-k-officials-argue-over-orkambi-price
http://www.pmlive.com/pharma_news/vertex_calls_nhs_england_outrageous_as_talks_stall_on_orkambi_access_1243362
http://www.pmlive.com/pharma_news/news_charity_criticises_nhs_england_and_vertex_over_orkambi_access,_sema_scores_again,_nodthera_launched_1241815
https://www.businesswire.com/news/home/20180618005495/en/Vertex-Announces-Long-Term-Access-Agreement-Sweden-Cystic
https://www.prnewswire.com/news-releases/proteostasis-announces-positive-data-from-ongoing-phase-1-study-of-pti-801-in-cystic-fibrosis-patients-on-background-orkambi-therapy-300661099.html
https://www.prnewswire.com/news-releases/proteostasis-announces-positive-data-from-ongoing-phase-1-study-of-pti-801-in-cystic-fibrosis-patients-on-background-orkambi-therapy-300661099.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-16-2018-1526446624.pdf
http://www.pharmatimes.com/news/ministers_write_letter_to_vertex_over_orkambi_debate_1232874
http://www.pharmatimes.com/news/vertex_offers_portfolio_approach_to_secure_access_to_cf_meds_1222691
https://www.fiercepharma.com/pharma/horizon-s-vimovo-gets-a-february-price-hike-its-11th-recent-years-report
Market Place
Share 
